229 related articles for article (PubMed ID: 35896234)
1. Prognostic Role of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 in Stage IV Colorectal Cancer.
Kawamura H; Honda M; Takano Y; Kinuta S; Kamiga T; Saji S; Kono K
Anticancer Res; 2022 Aug; 42(8):3921-3928. PubMed ID: 35896234
[TBL] [Abstract][Full Text] [Related]
2. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study.
Li Z; Zhu H; Pang X; Mao Y; Yi X; Li C; Lei M; Cheng X; Liang L; Wu J; Ding Y; Yang J; Sun Y; Zhang T; You D; Liu Z
BMC Cancer; 2022 Sep; 22(1):962. PubMed ID: 36076189
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
5. Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Anticancer Res; 2014 Jul; 34(7):3753-8. PubMed ID: 24982398
[TBL] [Abstract][Full Text] [Related]
6. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer.
Wang R; Xu B; Sun M; Pang X; Wang X; Zhu J; Lian J; Lu H
Eur J Surg Oncol; 2023 Dec; 49(12):107138. PubMed ID: 37925830
[TBL] [Abstract][Full Text] [Related]
7. Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer.
Rao H; Wu H; Huang Q; Yu Z; Zhong Z
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865243
[TBL] [Abstract][Full Text] [Related]
8. Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/III colon cancer.
Mizuno H; Miyake H; Nagai H; Yoshioka Y; Shibata K; Asai S; Takamizawa J; Yuasa N
Langenbecks Arch Surg; 2021 Sep; 406(6):1987-1997. PubMed ID: 34148158
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Clinical Diagnostic and Prognostic Value of Preoperative Serum Carcinoembryonic Antigen, CA19-9, and CA24-2 for Colorectal Cancer.
Hou S; Jing J; Wang Y; Du L; Tian B; Xu X; Sun T; Shi Y
Altern Ther Health Med; 2023 Sep; 29(6):192-197. PubMed ID: 37295009
[TBL] [Abstract][Full Text] [Related]
10. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
[TBL] [Abstract][Full Text] [Related]
12. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
[TBL] [Abstract][Full Text] [Related]
13. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer].
Qian X; Wang H; Ren Z; Jin F; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062
[No Abstract] [Full Text] [Related]
14. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
15. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
Morita S; Nomura T; Fukushima Y; Morimoto T; Hiraoka N; Shibata N
Dis Colon Rectum; 2004 Feb; 47(2):227-32. PubMed ID: 15043294
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.
Lin PC; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC
Int J Colorectal Dis; 2012 Oct; 27(10):1333-8. PubMed ID: 22426691
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.
Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X
Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155
[TBL] [Abstract][Full Text] [Related]
18. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
20. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.
Ishigami S; Natsugoe S; Hokita S; Che X; Tokuda K; Nakajo A; Iwashige H; Tokushige M; Watanabe T; Takao S; Aikou T
J Clin Gastroenterol; 2001 Jan; 32(1):41-4. PubMed ID: 11154168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
